Grace Therapeutics (GRCE)'s 30-day implied volatility (IV30) was 71.6% at the close on November 12, 2026, up from 71.1% the day before, against a 52-week range of 46.2% to 393.4%. Its 20-day historical volatility was 92.5%.

Key numbers

30-day implied volatility (IV30): 71.6%
IV30 52-week range: 46.2% to 393.4% (median 68.7%)
Historical volatility: 20-day 92.5%, 1-year 73.2%
Implied move by the nearest expiration: ±4.5%

Data as of November 12, 2026.

GRCE Implied Volatility (IV) vs Historical Volatility (HV)

Name: GRCE Implied Volatility
Creator: Market Chameleon